Diagnostic and Prognostic Value of Glycated Hemoglobin (HbA1c) in Patients with Diabetes Mellitus and Thalassemia Cover

.blurhash-client-img { display: none !important; }

Diagnostic and Prognostic Value of Glycated Hemoglobin (HbA1c) in Patients with Diabetes Mellitus and Thalassemia

Acta Medica Bulgarica

Volume 47 (2020): Issue 3 (September 2020)

By: E. Yordanov, E. Hristov, I. Parvova, V. Petkova and K. Andreevska

Open Access

|Oct 2020

Authors

E. Yordanov

emanuil.iordanov@gmail.com

Faculty of Chemistry and Pharmacy, Sofia University “Sveti Kliment Ohridski” – Sofia, Bulgaria

E. Hristov

Faculty of Chemistry and Pharmacy, Sofia University “Sveti Kliment Ohridski” – Sofia, Bulgaria

I. Parvova

Clinic of Rheumatology, Department of Internal Medicine, Medical University – Sofia, Bulgaria

V. Petkova

Faculty of Pharmacy, Medical University – Sofia, Bulgaria

K. Andreevska

Faculty of Chemistry and Pharmacy, Sofia University “Sveti Kliment Ohridski” – Sofia, Bulgaria

DOI: https://doi.org/10.2478/amb-2020-0027 | Journal eISSN: 2719-5384 | Journal ISSN: 0324-1750

Journal RSS Feed

Language: English

Page range: 13 - 17

Accepted on: Apr 8, 2020

Published on: Oct 14, 2020

Published by: Sofia Medical University

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

Diabetes mellitus,

glycated hemoglobin,

hemolytic anemia,

Related subjects:

Basic medical science,

Clinical medicine,

Clinical medicine, other

© 2020 E. Yordanov, E. Hristov, I. Parvova, V. Petkova, K. Andreevska, published by Sofia Medical University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous article Volume 47 (2020): Issue 3 (September 2020)Next article